Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 925-292-5 | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Animal Information:
One study was identified as key. (API, 1990; Klimisch score = 1). In an animal toxicokinetics metabolism and distribution study commercial hexane was metabolized and excreted within 168 hours of iv bolus administration, inhalation exposure or dermal application. Exhaled breath and urine were the two primary routes for the excretion and its metabolites. Commercial hexane was widely distributed to the body tissues but neither commercial hexane nor its metabolites were concentrated significantly by any of those tissues. It was extensively metabolized and a number of radio labeled metabolites were excreted in the urine. Commercial hexane and its radio labeled metabolites disappeared from the blood of rats with a half-life of approximately 9-10 hours. No significant differences between males and females were noted in the rates and routes of metabolism and excretion of the test compounds. Repeated inhalation exposure had no apparent effect on the rates or routes of excretion of either of the test compounds or their metabolites.
Human Information:
In a study in which metabolites in urine were measured in workers exposed to n-hexane (Perbellini et al., 1981), mean concentrations of n-hexane metabolites in urine were: 2,5-hexanedione, 5.4 mg/L; 2,5-dimethylfuran, 3.7 mg/L; gamma-valerolactone, 3.3 mg/L; and 2-hexanol, 0.19 mg/L. (2,5-Dimethylfuran and gammavalerolactone are believed to be artifacts of sample preparation and analysis rather than true metabolites of n-hexane (ATSDR, 1999)). The first reaction that takes place is hydroxylation of n-hexane at the 2 position to form 2-hexanol. Further reactions result in 2,5-hexanedione, presumably through transient intermediates, including 2-hexanone, 2,5-hexanediol, and 5-hydroxy-2-hexanone. Correlations between concentrations of n-hexane in air and urinary metabolites were best for total n-hexane metabolites (r=0.7858), followed by 2-hexanol (r=0.6851) and 2,5-hexanedione (r=0.6725).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
